Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics

P Brouckaert, N Takahashi, Sandra van Tiel, J Hostens, Lex Eggermont, ALB Seynaeve, W Fiers, Timo ten Hagen

Research output: Contribution to journalArticleAcademicpeer-review

55 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)442-448
Number of pages7
JournalInternational Journal of Cancer
Volume109
Issue number3
DOIs
Publication statusPublished - 2004

Research programs

  • EMC MM-03-47-11

Cite this